Results 231 to 240 of about 879,906 (340)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Alcohol Use, Coronary Heart Disease and Hypertension Modify the Predictive Accuracy of Pre-Operative CEA for TNM Staging in Chinese Colorectal Cancer Patients. [PDF]

Cancer Manag Res
Kuai D, Cheng J, Li R, Gao X, Sun L, Li Y, Sun W, Hu Y, Li C, Xu B.   +9 more
europepmc   +1 more source

Staging Shakespeare: (dis)solutions in intermedial processes

, 2019
Flávia Rodrigues Monteiro
openalex   +1 more source

Optimum Staging with Varying Thrust Attitude Angle

, 2014
T. N. Srivastava
openalex   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

A nomogram to predict prognosis of small-cell lung cancer patients in stage II based on the ninth edition of the tumor-node-metastasis staging system. [PDF]

J Cardiothorac Surg
Wu Y, Cheng Y, Dong Q, Fei Z, Shen J, Cai S.   +5 more
europepmc   +1 more source

Cardiac damage staging in heart valve diseases. “Metastatic disease or synchronous neoplasms”

Erwan Salaün, Josep Rodés‐Cabau
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Union for International Cancer Control 9^th Edition TNM Classification for Head and Neck Malignancies: What is New? [PDF]

Turk Arch Otorhinolaryngol
Bayram A, Çelebi Erdivanlı Ö, Society for Head and Neck Surgery Scientific Group.   +2 more
europepmc   +1 more source

International Staging System Stage [PDF]

, 2020
openaire   +1 more source